Product

APIs with DMF / COS or European Registered Drug Dossiers are suitably indicated in brackets. [Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. The liability of any sale into such protected markets is at buyer’s risk.]

Regular APIs
PRODUCT NAME PHARMACOPOEIA Regulatory Approvals Status REGULATORY APPROVAL THERAPEUTIC CLASS
USDMF CEP/EDMF Others
Atropine Sulfate USP, EP #29605 CEP China & Australia CEP EU GMP Mydriatic and cycloplegic
Chlorzoxazone *eCTD ready (#033920)
Clopidogrel Besylate (in tie up with Pharmathen) IHS EDMF GMP Antiplatelet
Dex Rabeprazole IHS ®EDMF ready GMP Proton pump inhibitor
Dexketoprofen Trometamol IHS *eCTD ready (#26959) EDMF Russia & MFDS (Korea) GMP, MFDS Analgesic
Diethyl Carbamazine Citrate USP, EP *eCTD ready (#26954) WHO EU GMP, WHO Anthelmintic
Febuxostat (in tie up with Pharmathen) IHS ®EDMF ready GMP Xanthine oxidase inhibitor
Homatropine Hydro Bromide BP, USP, EP ®EDMF ready GMP Anticholinergic medication Mydriatic and cycloplegic
Homatropine Methyl Bromide BP, USP, EP #23963 EDMF ANVISA EU GMP, USFDA Anticholinergic medication Mydriatic and cycloplegic
Ketorolac Tromethamine EP, USP EDMF Russia, MFDS (Korea) & ANVISA GMP Analgesic
Levofloxacin Hemihydrate USP, JP, IHS,EP ®EDMF ready EUGMP Broad Spectrum Antibiotic
Loxoprofen Sodium JP $JDMF filed GMP Non-steroidal anti-inflammatory drug, or NSAID
Nitisinone IHS US DMF is prepared (in Feb-2021) ®EDMF ready 4-hydroxyphenylpyruvate dioxygenase
Obidoxime Hydrochloride EDMF will be ready by Mar-2021 Antidote: Cholinesterase reactivator
Papaverine HCL US DMF will be ready by Apr-2021 China DMF will be ready by Apr-2021
Pregabalin (in tie up with Pharmathen) IHS EDMF GMP Anticonvulsant drug
Rebamipide JP $JDMF filed GMP Treatment of gastric Ulcers
APIs Launching
PRODUCT NAME PHARMACOPOEIA Regulatory Approvals Status REGULATORY APPROVAL THERAPEUTIC CLASS
USDMF CEP/EDMF Others
Carglumic Acid US DMF will be ready by Dec-2021
Clopidogrel Bisulfate (Form II) USP EDMF will be ready by Dec-21
Fursultiamine HCl
Ipratropium bromide USP, EP US DMF will be ready by Sep-2021 EDMF will be ready by Sep-2021 Bronchodilator
Ketoprofen EP, USP EDMF will be ready by Aug-2021 GMP Non-steroidal anti-inflammatory drug, or NSAID
Intermediates
1-(2-Ethoxyethyl)-1,3-Dihydrobenzoimidazol-2-One
Acetoxy Ethyl Bromide
Alpha-Methyl Cinnamic Aldehyde
BMC
Bromo Butryric Acid
Diethyl 2-Thienyl Methylmalonate
Hbr-48%(Fg)
L-Proline Benzyl Ester Hydrochloride
Para Nitro Benzyl Bromide
Pyclen Trihydrobromide
Pyrazine Compound
Scopine Di (2-Thienyl) Glycolate
VAM(2)

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. The liability of any sale into such protected markets is at buyer’s risk.